{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:20:15Z","timestamp":1767136815890,"version":"build-2238731810"},"reference-count":13,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We described a rare case of vaccine\u2010induced acalculous cholecystitis (ACC). A 52\u2010year\u2010old female developed ACC after 8\u00a0h of receiving a 3rd dose of the Pfizer\u2010BioNTech COVID\u201019 vaccination. The symptoms subsided completely with conservative treatment for 12\u2009days, and the ultrasound and laboratory findings went back to normal.<\/jats:p>","DOI":"10.1002\/ccr3.6078","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:43:53Z","timestamp":1657777433000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Friend or foe\u2014The\n                    <scp>Pfizer\u2010BioNTech<\/scp>\n                    (\n                    <scp>BNT162b2<\/scp>\n                    ) vaccination: A case report of reversible acute acalculous cholecystitis"],"prefix":"10.1002","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-2375","authenticated-orcid":false,"given":"Bianca Maria","family":"Wahlen","sequence":"first","affiliation":[{"name":"Department of Anesthesiology Hamad Medical Corporation (HMC)  Doha Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Peralta","sequence":"additional","affiliation":[{"name":"Department of Surgery, Trauma Surgery Hamad Medical Corporation (HMC)  Doha Qatar"},{"name":"Department of Surgery, School of Medicine Universidad Nacional Pedro Henr\u00edquez Ure\u00f1a  Santo Domingo Dominican Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Al\u2010Thani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Trauma and Vascular Surgery Hamad Medical Corporation (HMC)  Doha Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2584-953X","authenticated-orcid":false,"given":"Ayman","family":"El\u2010Menyar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Trauma and Vascular Surgery Clinical Research Hamad Medical Corporation (HMC)  Doha Qatar"},{"name":"Clinical Medicine Weill Cornell Medical College  Doha Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"World Health Organization (WHO).WHO status report: weekly epidemiological update on COVID\u201019 \u2010 14 December 2021.2021. Accessed December 20 2021.https:\/\/www.who.int\/emergencies\/diseases\/novel\u2010coronavirus\u20102019\/situation\u2010reports"},{"key":"e_1_2_11_3_1","unstructured":"Staista.Leading companies by number of COVID\u201019 drugs and vaccines in development as of December 16 2021.2021. Accessed December 20 2021.https:\/\/www.statista.com\/statistics\/1119090\/coronavirus\u2010drugs\u2010in\u2010development\u2010by\u2010leading\u2010companies\/"},{"key":"e_1_2_11_4_1","unstructured":"Centers for Disease Control and Prevention (CDC).Pfizer\u2010BioNTech COVID\u201019 vaccine reactions & adverse events.2021. Accessed December 20 2021.https:\/\/www.cdc.gov\/vaccines\/covid\u201019\/info\u2010by\u2010product\/pfizer\/reactogenicity.html"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"e_1_2_11_6_1","first-page":"4418","article-title":"Side effects after COVID\u201019 vaccinations among residents of Poland","volume":"25","author":"Andrzejczak\u2010Grazadko S","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC).Safety monitoring of an additional dose of COVID\u201019 vaccine \u2014 United States August 12\u2013September 19 2021.2021. Accessed December 20 2021.https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7039e4.htm?s_cid=mm7039e4_w","DOI":"10.15585\/mmwr.mm7039e4"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2020.04.007"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-020-00320-5"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05164-7"},{"issue":"8","key":"e_1_2_11_11_1","first-page":"001","article-title":"Adverse events reported from the COVID\u201019 vaccines: a descriptive study based on the WHO database (VigiBase\u00ae)","volume":"11","author":"Dutta S","year":"2021","journal-title":"J Appl Pharm Sci"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31823a08a6"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060576"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2022.41.291.33047"}],"updated-by":[{"DOI":"10.1002\/ccr3.6167","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000}}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.6078","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.6078","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.6078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:03:21Z","timestamp":1764306201000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.6078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1002\/ccr3.6078"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.6078","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"2022-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e6078"}}